Comparison of serum levels of seven-autoantibody (anti-CAGE, anti-GAGE7, anti-GBU4-5, anti-MAGE A1, anti-P53, anti-PGP9.5, and anti-SOX2) between LC patients and controls are shown in Table 2. This evidence concerns the gene TP53 and laryngotracheoesophageal cleft.